HeartFlow secures $240M in financing

AuntMinnie.com staff writers

Feb 15, 2018

Cardiovascular software developer HeartFlow has secured $240 million in financing, which it plans to use for marketing its fractional flow reserve (FFR) CT software, among other purposes.

HeartFlow's FFR-CT Analysis software helps clinicians diagnose and treat patients suspected of having coronary artery disease by creating a personalized 3D model, according to the firm.

Heart Pulmonary Trunk

CT-defined CAC predicts cardiovascular events in lung cancer patients

November 20, 2024

Head CT offers insight into old strokes

November 19, 2024

See the Future of Photon-Counting CT at RSNA 2024

See the Future of Photon-Counting CT at RSNA 2024

November 1, 2024

AI-enabled CCTA on par with IVUS for plaque quantification

November 14, 2024

CT-defined CAC predicts cardiovascular events in lung cancer patients

By Kate Madden Yee

CT-defined coronary artery calcification (CAC) scores can help predict the occurrence of conditions such as heart attack or stroke in lung cancer patients.

November 20, 2024

Heart Pulmonary Trunk

Head CT offers insight into old strokes

By Kate Madden Yee

Incidental discovery of old strokes on head CT imaging offers clinicians an opportunity to put measures against future strokes into place.

November 19, 2024

Climate change boosts emergency department use of x-ray, CT

By Kate Madden Yee

Climate change's effects -- particularly higher outdoor heat and air pollution -- increase imaging use in the emergency department, especially x-ray and CT.

November 19, 2024

Earth Thumbnail

AI-enabled CCTA on par with IVUS for plaque quantification

By Kate Madden Yee

An AI-powered automated plaque quantification tool for coronary CT angiography (CCTA) performs on par with intravascular ultrasound (IVUS) for quantifying heart plaque volume and characterizing plaque.

November 14, 2024

VR/AR helps clinicians diagnose diverticulitis on CT

By Kate Madden Yee

Virtual/augmented reality (VR/AR) headsets show promise for helping clinicians interpret CT exams -- even for conditions such as diverticulitis.

November 12, 2024

Digestive System 3 D Intestine

Choose wisely when it comes to neonatal liver imaging

By Kate Madden Yee

Newborns' livers can be affected by a variety of congenital and acquired diseases, and imaging plays an important role in the workup and management of these.

November 8, 2024

Baby Yawn Thumbnail

Tributes pour in for CT pioneer Willi Kalender

The medical imaging community has paid tribute to Willi Kalender, PhD, the renowned medical physicist.

November 6, 2024

2024 11 05 Willi Kalender Thumbnail

PCCT shows promise for generating opportunistic bone density data

By Kate Madden Yee

The use of PCCT spectral localization shows promise for opportunistic screening for low bone mass and osteoporosis and generating T-scores.

November 1, 2024

Ct Scanner Bore

Interobserver agreement modest on ILD diagnosed with CT imaging

By Kate Madden Yee

Interobserver agreement for assessing interstitial lung disease (ILD) using high-resolution CT (HRCT) is moderate, researchers have reported.

October 15, 2024

Caution needed when using LDCT with CAD systems for kids

By Kate Madden Yee

Caution is in order when using low-dose CT (LDCT) protocols with computer-aided-detection (CAD) systems for diagnosing small lung nodules in children

October 11, 2024

Ct Scanner Child

Extracardiac findings common on CT, MRI

By Kate Madden Yee

Clinically significant extracardiac findings are common on CT and MRI imaging and are especially associated with exam indication and patient age.

October 10, 2024

Photon-counting CT emerges as alternative for assessing fatty liver disease

Photon-counting CT may serve as an alternative to MRI for assessing liver fat in patients with fatty liver disease.

September 24, 2024

Liver fat content measurement with photon-counting CT and MRI-based proton density fat fraction (PDFF). Three regions of interest (circles) were delineated in the peripheral areas of the left, right anterior, and right posterior lobes of the liver. (A) Representative axial unenhanced 120-kVp standard-dose CT image (left) and corresponding MRI scan (right) in a 33-year-old man (body mass index, 26.2) diagnosed with metabolic dysfunction-associated steatotic liver disease (MASLD) in the asymptomatic cohort. (B) Representative axial unenhanced 120-kVp low-dose CT image (left) and corresponding MRI scan (right) in a 69-year-old woman (body mass index, 24.6) in the MASLD cohort. Body mass index was calculated as weight in kilograms divided by height in meters squared.

Page 1 of 660